Invitae Launches Expanded Pharmacogenomics Panel and Specialized Mental Health Panel

/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced the commercial availability of the expanded Invitae Pharmacogenomics...

Related Keywords

California ,United States ,Kristine Ashcraft ,Drug Administration ,Invitae Pharmacogenomics Pgx Panel ,Us Census Bureau ,Invitae Pharmacogenomics Mental Health Panel ,Exchange Commission ,Invitae Corporation ,Invitae Youscript Precision Prescribing Software ,Invitae Pharmacogenomics Panel ,Clinical Pharmacogenetics Implementation Consortium ,Invitae Pharmacogenomics ,Drug Dose Now Act ,Youscript Precision Prescribing Software ,Pharmacogenomics Mental Health Panel ,Private Securities Litigation Reform Act ,Quarterly Report ,